Sustained Release Excipients Market Growing at a CAGR of 6.8% Over the Forecast Period 2018 – 2026
Increasing innovative collaborative research opportunities in pediatric formulations is being pushed through evolution of new regulations, additional funding opportunities, and increased public-private partnerships.This has been focused to development of excipients used in all kinds of excipients such as oral solid dosage formulations and liquid pediatric formulation, which are flexible, dispersible and multi-functional. Furthermore, continued prioritization of unmet medical needs in pediatrics is expected to drive demand for these excipients and oral formulations in the forthcoming years. Ask Us Your Questions About This Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-7580 Growing Impact of Drug Abuse on Public Health Substance abuse has high impact on the health of individuals and their families. Prolonged drug and alcohol abuse may lead to mental illness and chronic diseases, such as diabetes and heart diseases, cancer, which in turn, can create high economic burden on the society. In order to curb this economic burden caused by drug abuse, governments are focusing on prevention and early intervention strategies are expected to drive demand for drugs of abuse. For instance, according to the Centers for Disease Control and Prevention (CDC), nearly 10 million individuals aged 55 and above were reported to seek treatment for cancer across the globe. in 2014. Moreover, it is estimated that nearly US$ 600 Bn is spent on addressing the impact caused by substance abuse each year in the U.S. Competitive LandscapeCompetition section of the sustained release excipients market features profiles of key players operating in the industry based on their market shares, differential strategies, product offerings, marketing approach and company dashboard. Examples of some of the key players featured in this report include FMC Corporation, Ashland Global Holdings, BASF Corporation, The Dow Chemical Company, Roquette Freres S.A. Colorcon Inc., Croda International Inc.The key manufacturers of sustained release excipients are focusing on novel marketing strategies to increase product penetration. The companies offering point-of-care sustained release excipients are concentrating on price floor strategies. These companies are offering their products with lucrative discounts. Conventional distribution channels, such as retail pharmacies, drug stores, supermarkets and hypermarkets are expected to be the key targets channel for local manufacturers. Definition: The sustained release excipients are one of the type of excipients that are added to the drug along with active pharmaceutical ingredients of medication. Sustained release excipients are pharmacologically non-active ingredients of the drug formulation. About the Report: The report offers a comprehensive evaluation of the business opportunities prevailing in the sustained release excipients market along with insights on the sustained release excipients consumption trend, disease incidences, and awareness level for sustained release excipients and sustained release excipients market competition. The report elaborates on the macroeconomic factors influencing the dynamics of sustained release excipients market and its futuristic potential. Research Methodology The sustained release excipients market has been estimated based on supply-demand approach. The market was first calculated based on allergy test volume conducted in different region/countries. The test volume was estimated based on the incidence rate of various types of allergies in the top 20 countries globally. Other qualitative factors analyzed during test volume estimation include awareness level for point care sustained release excipients, the recurrence rate of allergy reaction and others. This information is further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases). The research study on sustained release excipients market also includes top trends and macro as well as microeconomic factors shaping the sustained release excipients market. With this approach, the report on sustained release excipients market anticipates the industry attractiveness of every major segment in sustained release excipients market over the forecast period.SegmentationThe report offers a comprehensive taxonomy of sustained release excipients market based on product type, end user, route of administration route, and region.
The sustained release excipients are sold for various types of test samples, such as blood, skin, etc.
These sustained release excipients are used by pharmaceutical companies, biopharmaceutical companies, neutraceutical companies, and for various type of sustained release excipients, such as food allergies, drug allergies, latex allergies and other types of allergies.
End-use segments in the sustained release excipients market which are a part of this sustained release excipients market report include pharmaceutical companies, biopharmaceutical companies and other end users, such as nutraceutical manufacturers and contract manufacturing organisations.
The sustained release excipients market has been analyzed across regions of North America, Latin America, Europe, CIS & Russia, Asia Pacific and MEA.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years
Future Market Insights
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers, Dubai
United Arab Emirates